Patients with overlap syndromes present with both hepatitic and cholestatic biochemical and histological features of AIH, PBC, and/or PSC, and usually show a progressive course toward liver ...

Stroke remains a leading cause of disability and mortality worldwide, presenting a spectrum of neurological manifestations that challenge clinicians and researchers alike. This Research Topic aims to ...

The study commencement is based on previous clinical safety and efficacy data, along with robust preclinical evidence.

9月10-13日，第二届全球证据峰会（Global Evidence Summit ...

Sep. 10, 2024 — Feeling safe and comfortable are key when discussing your health and wellbeing with your primary care provider. However, that feeling of comfort and safety can't be taken for ...

Tebapivat 是一种新型丙酮酸激酶激活剂，目前正在研究用于治疗低风险骨髓增生异常综合征患者的贫血。 Tebapivat 是一种新型 PK 激活剂，已被 FDA 授予孤儿药资格，用于治疗低风险 MDS 引起的贫血。

Kendler, Kenneth S and Justis, Virginia 2023. The Development of Non-affective Psychotic Syndromes in the 19th Century: LeGrand du Saulle and His 1871 Monograph “Le Délire De Persécutions” ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

Chronic pain syndromes including fibromyalgia, dry eye disease, and irritable bowel syndrome showed no significant ...

Of note, the update is endorsed by EACTS, resolving some lingering left main debate, amid lots of other revised advice.

(RTTNews) - Agios Pharmaceuticals, Inc. (AGIO) Wednesday said the Food and Drug Administration or FDA has granted orphan drug designation to the company's drug candidate tebapivat for the treatment of ...